Patients With Type 2 Diabetes
Cohort Study of Patients With Type 2 Diabetes
1 other identifier
observational
2,000
1 country
1
Brief Summary
Diabetes mellitus
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 9, 2025
CompletedFirst Submitted
Initial submission to the registry
November 16, 2025
CompletedFirst Posted
Study publicly available on registry
November 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 21, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 21, 2028
March 30, 2026
September 1, 2025
2.9 years
November 16, 2025
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in nutritional status and physical function (including dietary habits, body composition, and grip strength)
Everytime after physician's appointment(Usually 3 months).
Study Arms (1)
Cohort Study of Patients With Type 2 Diabetes
Eligibility Criteria
This study will recruit adult participants aged 18 years or older who have been diagnosed with type 2 diabetes mellitus (T2DM), as confirmed by medical history, diagnostic codes, or current use of hypoglycemic medications. Eligible participants must be willing to join the study and provide written informed consent. In addition, they should be able to complete the required baseline assessments, including anthropometric and functional measurements such as height, weight, waist circumference, handgrip strength, and body composition.
You may qualify if:
- Adults aged 18 or older.
- Patients diagnosed with type 2 diabetes (based on medical history, diagnostic code, or use of hypoglycemic medication).
- Participants are willing to participate in the study and have signed the consent form.
- Participants are able to complete basic assessments (e.g., height, weight, waist circumference, grip strength, body composition, etc.).
You may not qualify if:
- Individuals who cannot understand the study content.
- Individuals who cannot cooperate with relevant assessments.
- Other individuals who are clinically deemed unsuitable for participation by the project leader.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Zhongzheng Dist, 100229, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chia-Wen Lu, Present Professor
Department of Family Medicine, National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2025
First Posted
November 24, 2025
Study Start
October 9, 2025
Primary Completion (Estimated)
August 21, 2028
Study Completion (Estimated)
August 21, 2028
Last Updated
March 30, 2026
Record last verified: 2025-09